Lisdexamfetamine Dosing for Adult ADHD
For adults with ADHD requiring consistent all-day symptom control and low abuse risk, start lisdexamfetamine at 30 mg once daily in the morning, then titrate weekly by 20 mg increments to a target dose of 50-70 mg/day based on symptom response and tolerability. 1
Starting Dose and Titration Schedule
The FDA-approved dosing regimen is straightforward:
- Week 1: Start at 30 mg once daily in the morning 1
- Week 2: Increase to 50 mg if needed and tolerated 1
- Week 3+: May increase to 70 mg (maximum approved dose) if additional symptom control is needed 1
This represents a more aggressive titration than older amphetamine guidelines that suggested 2.5-5 mg starting doses 2, but lisdexamfetamine's prodrug formulation allows for this approach.
Why Lisdexamfetamine Meets Your Specific Needs
All-day symptom control: Lisdexamfetamine provides approximately 13-14 hours of symptom control in adults 3, 4, making it superior for covering a full workday plus evening activities. The prodrug is enzymatically converted to active d-amphetamine primarily in red blood cells, creating consistent plasma concentrations throughout the day 4. Studies demonstrate maintained efficacy at 14 hours post-dose 3.
Low abuse potential: As a prodrug, lisdexamfetamine remains pharmacologically inactive until enzymatic hydrolysis occurs, which is unaffected by routes of administration that bypass the GI tract 4. This design inherently reduces abuse liability compared to immediate-release amphetamines 5, 6.
Dose-Response Considerations
The evidence shows clear dose-dependent improvements:
- All three doses (30,50,70 mg) demonstrated statistically significant superiority over placebo in adults 1
- Higher doses produced greater ADHD-RS-IV score reductions: 30 mg showed -8.0 point difference vs placebo, 50 mg showed -9.2, and 70 mg showed -10.4 1
- Patients with greater baseline symptom severity may benefit more from higher doses, particularly for hyperactive-impulsive symptoms 7
However, a 2024 meta-analysis found that unlicensed doses above 70 mg showed minimal additional benefit with increased adverse event dropouts 8. Stay within the 30-70 mg range—do not exceed 70 mg daily.
Monitoring Requirements
Assess at each dose adjustment (weekly during titration):
- ADHD symptom severity using standardized rating scales (ADHD-RS-IV)
- Blood pressure and pulse
- Appetite changes and weight
- Sleep quality and onset latency
- Mood disturbances, anxiety, or psychotic symptoms 9
Once stabilized on maintenance dose, monitor monthly until symptoms are fully controlled, then quarterly 2.
Common Pitfalls to Avoid
Don't add multiple daily doses: Unlike older immediate-release amphetamines that required 2-3 daily doses 2, lisdexamfetamine is dosed once daily only. Adding afternoon doses is unnecessary and increases adverse effects.
Don't titrate too slowly: The FDA-approved weekly titration schedule is appropriate 1. Slower titration delays symptom relief without improving tolerability.
Don't assume non-response at lower doses means treatment failure: Approximately 90% of patients respond when multiple stimulants are tried 2. If inadequate response at 70 mg lisdexamfetamine, consider switching to methylphenidate rather than exceeding the maximum dose.
Expected Adverse Effects
Most common treatment-emergent adverse events are mild-to-moderate and transient 4:
- Decreased appetite (most frequent)
- Insomnia
- Dry mouth
- Increased heart rate/blood pressure
These typically diminish after the first few weeks. If prohibitive side effects occur (severe anorexia, insomnia >1.5 hours, marked agitation), reduce dose or switch medications 2.
Maintenance Treatment
Once optimal dose is achieved, continue indefinitely as long as symptoms remain controlled and medication is tolerated. A randomized withdrawal study demonstrated that only 9% of adults on lisdexamfetamine experienced treatment failure versus 75% switched to placebo over 6 weeks 1, confirming that ongoing treatment is necessary to maintain benefits.